Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NATALIA OBANDO CABREJO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1568928471
CMS profile
6308597
Location
BAKERSFIELD, CA

General Payments · PY2021–2024

$1,976.11

  • Reported across 76 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$407.72

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $407.72 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $460.65 16
PY2022 $438.22 17
PY2023 $669.52 26
PY2024 $407.72 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $27.75 02/24/2024 Food and Beverage Undisputed 01/23/2026 1117341592 CMS
Amgen Inc. $14.18 04/22/2024 Food and Beverage Undisputed 01/23/2026 1117341594 CMS
AstraZeneca Pharmaceuticals LP $21.74 11/27/2024 Food and Beverage Undisputed 01/23/2026 1123308468 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.65 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118063508 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.58 11/14/2024 Food and Beverage Undisputed 01/23/2026 1118063506 CMS
Inspire Medical Systems, Inc. $24.60 12/10/2024 Food and Beverage Undisputed 01/23/2026 1148164369 CMS
iRhythm Technologies, Inc. $21.12 02/14/2024 Food and Beverage Undisputed 01/23/2026 1154043523 CMS
iRhythm Technologies, Inc. $23.74 07/02/2024 Food and Beverage Undisputed 01/23/2026 1154043527 CMS
Kiniksa Pharmaceuticals International, plc $17.06 02/13/2024 Food and Beverage Undisputed 01/23/2026 1154860076 CMS
Kiniksa Pharmaceuticals International, plc $13.90 09/27/2024 Food and Beverage Undisputed 01/23/2026 1154860156 CMS
Merck Sharp & Dohme LLC $21.99 01/30/2024 Food and Beverage Undisputed 01/23/2026 1141951975 CMS
Merck Sharp & Dohme LLC $20.73 02/29/2024 Food and Beverage Undisputed 01/23/2026 1141812913 CMS
Novartis Pharmaceuticals Corporation $33.65 01/04/2024 Food and Beverage Undisputed 01/23/2026 1087200247 CMS
Novartis Pharmaceuticals Corporation $20.71 01/11/2024 Food and Beverage Undisputed 01/23/2026 1087200249 CMS
Novartis Pharmaceuticals Corporation $25.98 02/27/2024 Food and Beverage Undisputed 01/23/2026 1087200271 CMS
PFIZER INC. $24.26 10/16/2024 Food and Beverage Undisputed 01/23/2026 1132128189 CMS
SCPHARMACEUTICALS INC. $48.08 07/31/2024 Food and Beverage Undisputed 01/23/2026 1132290940 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.